Crossmark

Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole

Published Online: 2021-06-20

Published Print: 2022-05

Authors

Sun, Yuzhu

Chen, Dongmei

Zhao, Ying

Zhou, Kaixiang

Zhang, Bao

Wang, Haiting

Xie, Shuyu
License Information

Text and Data Mining valid from 2021-06-20

Version of Record valid from 2021-06-20
More Information

Article History

Accepted: 31 May 2021

First Online: 20 June 2021

Declarations

:

: The authors declare no competing interests.

Document is current